The rise in research activities and growing demand for Immuno Oncology Assays Market is projected to bring bright opportunities for the market of sample preparation

The immuno-oncology assays are valuable tools in the fight against cancer. These newest methods help to determine how new drugs will interact with existing products and agents, researchers and doctors can design preventative drug plans and better target the treatment of malignant tumors. These assays have been developed to measure the ability of tumor cells to resist various viruses, bacteria, chemicals, and pesticides. These assays are important for both research and pre-clinical development of vaccines, medicines, and drugs.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/2632

The rising prevalence of cancer around the globe is a prime factor driving the growth of the immuno oncology assays market. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. The immuno-oncology assay is widely used in clinical trials because it helps in reducing the cost of research and also improves the efficiency of therapies. Additionally, these assays enable easy understanding of the compound’s response intended to mimic the tumor microenvironment. Furthermore, these assays offer important information to confirm the efficiency of a drug and also provide easier & faster analysis of cancer. This is further anticipated to foster the growth of the immuno oncology assays market.

North America is expected to gain significant growth over the forecast period and this is attributed to the increased spending by the government on the research and development for developing novel drugs and biomarkers. According to the 7 American Medical Association, a recent estimate of cancer drug R&D spending was $2.7 billion (2017 US dollars). Also, the presence of strong players in the region such as Thermo Fisher and Illumina, Inc that are highly engaged in the clinical trials activities is further anticipated to foster the regional market growth.

Key Developments:

1. In February 2020, Biocare Medical, a provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announced the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications.

2. In December 2019, 2cureX AB announced that the company presented significant progression of the IndiTreat® test for individualizing immuno-oncological treatment at the ESMO IO Congress.

3. In November 2019, QIAGEN announced a series of agreements that expand its immuno-oncology assets for future commercialization of novel companion diagnostics for precision medicine in immuno-oncology, in particular, based on the powerful next-generation sequencing (NGS) technology.

Major Key Players Include In Immuno Oncology Assays Market: Roche Diagnostics, Agilent Technologies, Qiagen, Merck, Thermo Fischer scientific, HTG Molecular Diagnostics, Perkinelmer, Sartorius AG, and lllumina, Merck, Perkinelmer.

Buy instant copy of this research report with Flat US $ 2000 Off@ https://www.coherentmarketinsights.com/promo/buynow/2632

Main points in Immuno Oncology Assays Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immuno Oncology Assays Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Immuno Oncology Assays Industry Impact

Chapter 2 Global Immuno Oncology Assays Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immuno Oncology Assays (Volume and Value) by Type
2.3 Global Immuno Oncology Assays (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Immuno Oncology Assays Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Immuno Oncology Assays Market Analysis
Chapter 6 East Asia Immuno Oncology Assays Market Analysis
Chapter 7 Europe Immuno Oncology Assays Market Analysis
Chapter 8 South Asia Immuno Oncology Assays Market Analysis
Chapter 9 Southeast Asia Immuno Oncology Assays Market Analysis
Chapter 10 Middle East Immuno Oncology Assays Market Analysis
Chapter 11 Africa Immuno Oncology Assays Market Analysis
Chapter 12 Oceania Immuno Oncology Assays Market Analysis
Chapter 13 South America Immuno Oncology Assays Market Analysis
Chapter 14 Company Profiles and Key Figures in Immuno Oncology Assays Business
Chapter 15 Global Immuno Oncology Assays Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Continued…

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2632

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com